STAT3 and colitis: It also inhibits the progression from colitis to colon cancer in a 1, 2-dimethylhydrazine (DMH)/DSS-induced mouse model and downregulates the JAK–STAT3 pathway by the phosphorylation of STAT3 in colorectal cancer cells [146].